Produkty 68-54-2

CAS 68-54-2 występuje w naszej ofercie pod nazwami: 5beta-Dihydrocortisone, >95% (HPLC), 5b-Dihydrocortisone, >95% (HPLC), 5β–Dihydrocortisone, 5β-Dihydrocortisone, ≥98%, ≥98%. Oferty producentów: TRC, GLPBio, Chemat. Dostępne opakowania: 100mg, 1g, 10mg, 10mM (in 1ml dmso), 25mg, 250mg, 500mg.

5beta-Dihydrocortisone, >95% (HPLC)
TRC
  • opakowanie: 100mg
  • Warianty: 1
Zobacz produkt
5b-Dihydrocortisone, >95% (HPLC)
TRC
  • opakowanie: 1g
  • Warianty: 1
Zobacz produkt
5β–Dihydrocortisone
GLPBio
  • opakowanie: 10mg, 10mM (in 1ml dmso)
  • Warianty: 2
od 625,12
Zobacz produkt
5β-Dihydrocortisone, ≥98%, ≥98%
Chemat
  • opakowanie: 25mg, 100mg, 250mg, 500mg
  • Warianty: 4
od 1322,00
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(5R,8S,9S,10S,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,4,5,6,7,8,9,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,11-dione (CAS 68-54-2) to związek chemiczny o wzorze sumarycznym C21H30O5 i masie molowej 362.5 g/mol. Nazwa systematyczna IUPAC: (5R,8S,9S,10S,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,4,5,6,7,8,9,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,11-dione. InChIKey: YCLWEYIBFOLMEM-FNLRALKVSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H30O5
Masa molowa362.5 g/mol
Nazwa IUPAC(5R,8S,9S,10S,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,4,5,6,7,8,9,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,11-dione
InChIKeyYCLWEYIBFOLMEM-FNLRALKVSA-N
SMILESC[C@]12CCC(=O)C[C@H]1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 4,5beta-Dihydrocortisone, 5beta-Dihydrocortisone, 5|A-Dihydrocortisone, 17,21-dihydroxy-5beta-pregnane-3,11,20-trione, 17alpha,21-Dihydroxy-5beta-pregnane-3,11,20-trione, 5beta-Pregnane-17alpha,21-diol-3,11,20-trione, 5b-Dihydrocortisone, 5.beta.-Dihydrocortisone, Dihydrocortisone, (5beta)-, 5??-Dihydrocortisone
Izomery (ten sam wzór sumaryczny)
6,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5
(8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-13-(hydroxymethyl)-10-methyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O5
3,4-dihydroxy-2-(2-methylbutanoyl)-5-(3-methylbut-2-enyl)-4-(4-methylpent-3-enoyl)cyclopent-2-en-1-one C21H30O5
(8S,10R,11S,13S)-9,11,12,12-tetradeuterio-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one C21H30O5
2-[[(8R,9S,10S,13S,14S,17S)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-10-yl]methoxy]acetic acid C21H30O5
2-hydroxy-2-[(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]acetic acid C21H30O5
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5
(8S,9S,10R,11S,13S,14S,17R)-17-[(1R)-1,2-dihydroxyethyl]-11,17-dihydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C21H30O5
3,5,6-trihydroxy-2-(2-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one C21H30O5
(8S,9S,10R,11S,13S,14S,17S)-17-(2,2-dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O5
(8S,9S,10R,11R,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5
(8S,9S,10R,11S,13S,14S,17S)-1,2-dideuterio-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5